Pharmacology of terazosin: an alpha 1-selective blocker.
Kyncl
J J
JJ
D000317:Adrenergic alpha-Antagonists / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D011224:Prazosin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha / Q000737:chemistry / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D011942:Receptors, Adrenergic, alpha; D014665:Vasodilator Agents; C041226:Terazosin; D011224:Prazosin